You have accessJournal of UrologyProstate Cancer: Localized: Radiation Therapy (PD08)1 Sep 2021PD08-07 ASSOCIATION BETWEEN PELVIC NODAL RADIOTHERAPY AND PATIENT-REPORTED OUTCOMES AMONG MEN UNDERGOING EXTERNAL-BEAM RADIOTHERAPY FOR PROSTATE CANCER Christopher Wallis, Jacob Tallman, Li-Ching Huang, Zhiguo Zhao, David Penson, Tatsuki Koyama, Ralph Conwill, Michael Goodman, Ann Hamilton, Xiao-Cheng Wu, Lisa Paddock, Antoinette Stroup, Matthew Cooperberg, Mia Hashibe, Brock O'Neil, Sherrie Kaplan, Sheldon Greenfield, Daniel Barocas, and Karen Hoffman Christopher WallisChristopher Wallis More articles by this author , Jacob TallmanJacob Tallman More articles by this author , Li-Ching HuangLi-Ching Huang More articles by this author , Zhiguo ZhaoZhiguo Zhao More articles by this author , David PensonDavid Penson More articles by this author , Tatsuki KoyamaTatsuki Koyama More articles by this author , Ralph ConwillRalph Conwill More articles by this author , Michael GoodmanMichael Goodman More articles by this author , Ann HamiltonAnn Hamilton More articles by this author , Xiao-Cheng WuXiao-Cheng Wu More articles by this author , Lisa PaddockLisa Paddock More articles by this author , Antoinette StroupAntoinette Stroup More articles by this author , Matthew CooperbergMatthew Cooperberg More articles by this author , Mia HashibeMia Hashibe More articles by this author , Brock O'NeilBrock O'Neil More articles by this author , Sherrie KaplanSherrie Kaplan More articles by this author , Sheldon GreenfieldSheldon Greenfield More articles by this author , Daniel BarocasDaniel Barocas More articles by this author , and Karen HoffmanKaren Hoffman More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000001976.07AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: The role of pelvic radiotherapy in men undergoing external-beam radiotherapy (EBRT) for prostate cancer remains controversial. We sought to compare patient-reported outcomes (PROs) for men receiving whole pelvis radiotherapy (WPRT) versus prostate-only radiotherapy (PORT), longitudinally over 5 years. METHODS: CEASAR is a multi-institution prospective population-based cohort study of men with clinically localized prostate cancer from 2011-2012. We compared PROs between men receiving WPRT vs. PORT using the validated 26-item Expanded Prostate Index Composite and Short Form Health Survey. We fit multivariable longitudinal linear regression models adjusting for demographics, clinical data, baseline PROs, and propensity scores to mitigate confounding by indication. RESULTS: Among 587 men treated with EBRT, 102 (17%) received WPRT while 485 (83%) received PORT. Men who received WPRT were more likely to have high-risk disease (58% vs. 18%) and to receive androgen deprivation therapy. In unadjusted analysis, disease-specific functional outcomes were similar between WPRT and PORT groups from baseline through 5 years, with the exception of worse sexual (from 6 months to 5 years) and hormonal function (at 6 months) with WPRT. In adjusted analyses, no significant differences were found in most PROs through 5-years except marginally clinically significant differences in hormonal function at 3-years (adjusted mean difference 4.7, 95% CI [1.2-8.3]; minimum clinically important difference 4-6) and 5-years (4.2, [0.4-8.0]) following treatment.Crude estimates of general health-related function identified baseline differences between treatment groups in physical functioning which persisted over time, but not in other domains. In adjusted analyses, we found a transient statistically, but not clinically, significant difference in emotional well-being at 6 months that resolved by 1 year and no differences in physical functioning or energy and fatigue. CONCLUSIONS: In this large, prospective cohort of men with localized prostate cancer, the use of pelvic, in addition to prostate, radiation therapy was not associated with clinically important differences in patient-reported outcomes through five years. Source of Funding: This study was supported by the Agency for Healthcare Research and Quality (1R01HS019356, 1R01HS022640), the Patient-Centered Outcomes Research Institute (CE-12-11-4667), and the National Cancer Institute (NIH/NCI grant 5T32CA106183). Data management was facilitated by Vanderbilt University’s Research Electronic Data Capture (REDCap) system, which is supported by the Vanderbilt Institute for Clinical and Translational Research grant (UL1TR000011 from NCATS/NIH) © 2021 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 206Issue Supplement 3September 2021Page: e116-e116 Advertisement Copyright & Permissions© 2021 by American Urological Association Education and Research, Inc.MetricsAuthor Information Christopher Wallis More articles by this author Jacob Tallman More articles by this author Li-Ching Huang More articles by this author Zhiguo Zhao More articles by this author David Penson More articles by this author Tatsuki Koyama More articles by this author Ralph Conwill More articles by this author Michael Goodman More articles by this author Ann Hamilton More articles by this author Xiao-Cheng Wu More articles by this author Lisa Paddock More articles by this author Antoinette Stroup More articles by this author Matthew Cooperberg More articles by this author Mia Hashibe More articles by this author Brock O'Neil More articles by this author Sherrie Kaplan More articles by this author Sheldon Greenfield More articles by this author Daniel Barocas More articles by this author Karen Hoffman More articles by this author Expand All Advertisement Loading ...
Read full abstract